Dr. Eisenhauer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114Phone+1 617-724-4800Fax+1 617-724-6009
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Gynecologic Oncology, 2004 - 2008
- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 2000 - 2004
- University of California San Diego School of MedicineClass of 2000
Certifications & Licensure
- MA State Medical License 2018 - 2025
- OH State Medical License 2008 - 2019
- NY State Medical License 2004 - 2010
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
- Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
- Join now to see all
Publications & Presentations
PubMed
- 159 citationsA new frontier for quality of care in gynecologic oncology surgery: multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model.Giovanni Aletti, Antonio Santillan, Eric L. Eisenhauer, Jae Hu, Giacomo Aletti
Gynecologic Oncology. 2007-10-01 - 2 citationsTrends in the use of neoadjuvant chemotherapy for low-grade serous ovarian cancer in the United States.Jason N Silberman, Alexandra S Bercow, Allison A Gockley, Eric L Eisenhauer, Rachel Sisodia
Gynecologic Oncology. 2023-08-01 - 142 citationsNCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022.Deborah K Armstrong, Ronald D Alvarez, Floor J Backes, Jamie N Bakkum-Gamez, Lisa Barroilhet
Journal of the National Comprehensive Cancer Network. 2022-09-01
Press Mentions
- Lymphadenectomy in Advanced Ovarian Cancer: Will It Improve Survival?March 19th, 2019
- Lymphadenectomy Often Useless in Ovarian CancerMarch 1st, 2019
- Dr. Eric L. Eisenhauer Has Been Recognized Among the Top in His Industry by the Expert Network©January 21st, 2016
Professional Memberships
- Society of Gynecologic OncologyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: